about
Simultaneous determination of bupropion, metroprolol, midazolam, phenacetin, omeprazole and tolbutamide in rat plasma by UPLC-MS/MS and its application to cytochrome P450 activity study in rats.Determination and validation of hupehenine in rat plasma by UPLC-MS/MS and its application to pharmacokinetic study.Pharmacokinetic study of dendrobine in rat plasma by ultra-performance liquid chromatography tandem mass spectrometry.Pharmacokinetic study of ardisiacrispin A in rat plasma after intravenous administration by UPLC-MS/MS.Pharmacokinetic interaction study combining lapatinib with vorinostat in rats.Pharmacokinetic interaction study of combining imatinib with dasatinib in rats by UPLC-MS/MS.Doxorubicin-loaded redox-responsive micelles based on dextran and indomethacin for resistant breast cancer.Silibinin affects the pharmacokinetics of methadone in rats.Indomethacin-based stimuli-responsive micelles combined with paclitaxel to overcome multidrug resistance.Identification and characterization of a novel CYP2C9 allelic variant in a warfarin-sensitive patient.Determination of N-methylcytisine in rat plasma by UPLC-MS/MS and its application to pharmacokinetic study.Pharmacokinetics and bioavailability of gelsenicine in mice by UPLC-MS/MSEvaluation of the effect of apatinib (YN968D1) on cytochrome P450 enzymes with cocktail probe drugs in rats by UPLC-MS/MSValidated UPLC-MS/MS method for determination of hordenine in rat plasma and its application to pharmacokinetic studyPharmacokinetics and Bioavailability Study of Tubeimoside I in ICR Mice by UPLC-MS/MSQuantitative determination of talatisamine and its pharmacokinetics and bioavailability in mouse plasma by UPLC-MS/MS
P50
Q35541824-D1163F56-53B1-43FE-A72C-16B86449F52FQ35649224-944664B3-3711-4D27-8312-2ADA2CCD549AQ35829389-60E6A5A2-62B2-4252-ABA7-844E5A6FE336Q36114588-2653B824-F1DB-4F98-98E2-15C78BEF6093Q41036230-45F355F2-E15F-489E-A929-8F7FD46B1B50Q41509859-B65F320F-EE10-4B0E-868C-DD9AA5D9B88BQ41545913-E56AB4B6-F2DD-4A40-890D-72BC48CACCC9Q48231856-35CF9DE2-8D57-4A8E-84D2-E5D660FDA959Q49183417-8FB57096-CE52-4B7A-96A5-3551358BAA35Q52814257-BAD468E3-A729-4E6B-8CD9-D74ED8BA2B57Q53546453-6639F8C8-A873-49A4-87D2-F2B0669D81B6Q58112805-1BDE34D9-F8DD-471B-8078-61B0793222D3Q86162329-5D44636E-0E0E-44CA-BAC0-B34E1EE1F16FQ87126813-BA034D8F-5005-4518-A370-971E7054AE65Q90992380-688B5808-934B-4DA3-ABC5-93979E8684D3Q92812330-3FE2B677-857A-4448-A572-CB346C9ACA7D
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Yunfang Zhou
@en
Yunfang Zhou
@nl
type
label
Yunfang Zhou
@en
Yunfang Zhou
@nl
prefLabel
Yunfang Zhou
@en
Yunfang Zhou
@nl
P31
P496
0000-0002-4317-0865